1-(2-Nitrophenyl)thiosemicarbazides: A Novel Class of Potent, Orally Active Non-Peptide Antagonist for the Bradykinin B2 Receptor
- 12 February 2000
- journal article
- letter
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 43 (5) , 769-771
- https://doi.org/10.1021/jm991155o
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Bradyzide, a potent non‐peptide B2 bradykinin receptor antagonist with long‐lasting oral activity in animal models of inflammatory hyperalgesiaBritish Journal of Pharmacology, 2000
- Expression cloning of a human B1 bradykinin receptor.Journal of Biological Chemistry, 1994
- Design of potent non-peptide competitive antagonists of the human bradykinin B2 receptorJournal of Medicinal Chemistry, 1993
- Hoe 140 a new potent and long acting bradykinin‐antagonist: in vivo studiesBritish Journal of Pharmacology, 1991
- Bradykinin receptor antagonistsMedicinal Research Reviews, 1990
- Bradykinin as a pain mediator: receptors are localized to sensory neurons, and antagonists have analgesic actions.Proceedings of the National Academy of Sciences, 1988
- Antinociceptive effects of bradykinin antagonistsEuropean Journal of Pharmacology, 1987
- Competitive antagonists of bradykininPeptides, 1985
- LIGAND: A versatile computerized approach for characterization of ligand-binding systemsAnalytical Biochemistry, 1980